creatine has been researched along with Fever of Unknown Origin in 1 studies
Fever of Unknown Origin: Fever in which the etiology cannot be ascertained.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hundred consecutive neutropenic patients with hematological malignancies and persistent fever after 72 h of first-line antibiotic therapy (91% piperacillin/tazobactam) were treated with teicoplanin (800 mg on day 1, then 400 mg/day)+piperacillin/tazobactam+gentamicin from 08/96 to 09/00 (group T) or with vancomycin (2 g/day)+meropenem+levofloxacin from 10/00 to 04/02 (group V)." | 7.74 | An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant? ( Arns, A; Glasmacher, A; Hahn-Ast, C; Marklein, G; Mühling, A; Orlopp, K; Von Lilienfeld-Toal, M, 2008) |
| "Hundred consecutive neutropenic patients with hematological malignancies and persistent fever after 72 h of first-line antibiotic therapy (91% piperacillin/tazobactam) were treated with teicoplanin (800 mg on day 1, then 400 mg/day)+piperacillin/tazobactam+gentamicin from 08/96 to 09/00 (group T) or with vancomycin (2 g/day)+meropenem+levofloxacin from 10/00 to 04/02 (group V)." | 3.74 | An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant? ( Arns, A; Glasmacher, A; Hahn-Ast, C; Marklein, G; Mühling, A; Orlopp, K; Von Lilienfeld-Toal, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn-Ast, C | 1 |
| Glasmacher, A | 1 |
| Arns, A | 1 |
| Mühling, A | 1 |
| Orlopp, K | 1 |
| Marklein, G | 1 |
| Von Lilienfeld-Toal, M | 1 |
1 other study available for creatine and Fever of Unknown Origin
| Article | Year |
|---|---|
An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
Topics: Anti-Bacterial Agents; Creatine; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; | 2008 |